SCHEMBL24314287

SCHEMBL24314287

CC(C)(C)c1ccc(OCC2CC2)c(I)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 1/20 0.44
HTR2C P28335 5/20 0.38
HTR2B P41595 4/20 0.38
HTR2A P28223 3/20 0.38
KDM4E B2RXH2 3/20 0.38
PDE4B Q07343 2/20 0.37
ALDH1A1 P00352 2/20 0.37
EP300 Q09472 1/20 0.37
CNR1 P21554 1/20 0.37
CNR2 P34972 1/20 0.37
PDE4A P27815 1/20 0.37
PDE4C Q08493 1/20 0.37
PDE4D Q08499 1/20 0.37
HSD17B10 Q99714 1/20 0.37
DHFR P00374 1/20 0.37
NPSR1 Q6W5P4 2/20 0.36
CYP2C19 P33261 1/20 0.36
MAPT P10636 1/20 0.36
MAPK1 P28482 1/20 0.36
RECQL P46063 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29469863 1.00 RIPK1 (0.44) RIPK1HTR2CHTR2BHTR2AKDM4E
SCHEMBL24334343 0.84 KDM4E (0.54) RIPK1HTR2CHTR2BHTR2AKDM4E
SCHEMBL20206824 0.81 RIPK1 (0.44) RIPK1HTR2CHTR2BHTR2AKDM4E
SCHEMBL24314185 0.81 KDM4E (0.47) KDM4E
SCHEMBL20347948 0.79 RIPK1 (0.45) RIPK1HTR2CHTR2BHTR2AKDM4E
SCHEMBL20347946 0.78 DUT (0.46) RIPK1HTR2CHTR2BHTR2AEP300
SCHEMBL18120365 0.78 RIPK1 (0.44) RIPK1HTR2CHTR2BCNR1CNR2
SCHEMBL24314284 0.78 RIPK1 (0.41) RIPK1HTR2CHTR2BHTR2AKDM4E
SCHEMBL22588350 0.77 ALDH1A1 (0.47) RIPK1ALDH1A1HSD17B10NPSR1HTT
SCHEMBL25111149 0.77 PDE4B (0.56) PDE4BPDE4APDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022081807-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO disclosed
WO-2022081842-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO disclosed